CD19 and neoplasm: For instance, the biopsy of a patient with plasmablastic lymphoma (PBL) had tumor cells lacking CD19 and other markers of pre-plasmacytic B-cell differentiation, suggesting that PBL might have used alternative B-cell differentiation pathways to proliferate and avoid apoptosis [54].